Clinical Trial Update: UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating UGT1A1-based irinotecan therapy for locally advanced rectal cancer (Stage III) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• UGT1A1-based irinotecan therapy (UGT1A1-based irinotecan therapy)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Rectal Cancer Stage III | Phase 4 | Status: RECRUITING